Q3 2025 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsKevin LorenzMichael Drolshagen - CEO, CTO & Chairman ...
Drug resistance remains the foremost challenge to durable cancer control. Tumors evolve dynamic mechanisms to evade therapy through target mutations, ...
In Part 1, we explored the background of CMMC, discussed the timeline of its implementation and laid the groundwork for why ...
Court held that assignment of leasehold rights amounts to transfer of immovable property and not supply of service, thereby exempting it from GST ...
The China Association for Science and Technology has launched this year's special talent cultivation project for PhD students, further expanding the scale and scope of funding to develop the ...
How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...
NCEF–3 expands its scope to twenty priority materials and focuses on actionable implementation, measurable outcomes, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback